Quotidiano Nazionale logo
il Giorno logo
Quotidiano Nazionale logo
il Giorno logo
13 ago 2022

Borotalco Johnson&Johnson: stop alla vendita dal 2023. Troppe cause per tumore

Il colosso americano interromperà la vendita in tutto il mondo

13 ago 2022
Johnson's baby powder remains stocked at a supermarket shelf on August 22, 2017 in Alhambra, California, where a Los Angeles jury on August 21 ordered Johnson & Johnson to pay a record $417 million to a woman in hospital who sued the company.
A California jury on August 21, 2017 ordered drugmaker Johnson & Johnson to pay 417 million dollars to a woman who claimed she developed terminal ovarian cancer after using the company's talc-based products.The case was one of thousands of lawsuits brought nationwide alleging the company failed to warn consumers of the risk of cancer from talc in its products.
 / AFP PHOTO / FREDERIC J. BROWN
Un prodotto della Johnson & Johnson (Afp)
Johnson's baby powder remains stocked at a supermarket shelf on August 22, 2017 in Alhambra, California, where a Los Angeles jury on August 21 ordered Johnson & Johnson to pay a record $417 million to a woman in hospital who sued the company.
A California jury on August 21, 2017 ordered drugmaker Johnson & Johnson to pay 417 million dollars to a woman who claimed she developed terminal ovarian cancer after using the company's talc-based products.The case was one of thousands of lawsuits brought nationwide alleging the company failed to warn consumers of the risk of cancer from talc in its products.
 / AFP PHOTO / FREDERIC J. BROWN
Un prodotto della Johnson & Johnson (Afp)
Hai già un abbonamento?
Questo articolo è riservato agli abbonati

Accedi senza limiti a tutti i contenuti di ilgiorno.it e dei siti collegati.Naviga senza pubblicità!

Accesso per un giorno

0,99 € per 24hSenza rinnovo automatico
Oppure

Disdici quando vuoi

mese
anno
Scopri le altre offerte

Iscriviti alla newsletter.

Il modo più facile per rimanere sempre aggiornati

Hai già un account?